|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Prevention of contrast-induced nephropathy:a single center randomized study显示文摘 | Castini D Lucreziotti S Bosotti L | | 0，，： | 1 |
| 2 | Stochastic modelling of wind velocities time series 显示文摘 | Castini F Festa R Ratto C F | 1998 | Wind Eng Ind Aerodynamics1998，7476，： | 1 |
| 3 | Prevention of contrast- in- duced nephropathy: a single center randomized study显示文摘 | Castini D Luereziotti S Bosotti L | 2010 | Clin Car- diol2010，33，3： | 1 |
| 4 | Prevention of Contrast - in- duced Nephropathy: A Single Center Randomized Study 显示文摘 | Castini D Lucreziotti S Bosotti L | 2010 | Clin Cardiol2010，33，： | 1 |
| 5 | Prevention of contrastinduced Nephropathy: a single center randomized study 显示文摘 | Castini D Lucreziotti S Bosotti L | 2010 | ClinCardiol2010，33，3： | 1 |
| 6 | Evaluation of Systolic Time Intervals in a Group of Healthy Children 10-12 Years Old 显示文摘 | VITOLO E COLOMBO A CASTINI D | 1991 | Acta Cardiol1991，46，6： | 1 |
| 7 | Neutrophilderived superoxide anion induces lipid peroxidation and stimulates collagen synthesis in human hepatic stellate cells role of nitric oxide显示文摘 | Castini A Ceni E Slzano | 1997 | Hepatology1997，25，2： | 1 |
| 8 | Extracorporeal veno-venous ultrafiltration in congestive heart failure:What’s the state of the art?A mini-review显示文摘Hospitalizations for heart failure exceed 1 million per year in both the United States and Europe and more than 90%are due to symptoms and signs of fluid overload.Rates of rehospitalizations or emergency department visit at 60 days are remarkable regardless of whether loop diuretics were administered at low vs high doses or by bolus injection vs continuous infusion.Ultrafiltration(UF)has been considered a promising alternative to stepped diuretic therapy and it consists in the mechanical,adjustable removal of iso-tonic plasma water across a semipermeable membrane with the application of hydrostatic pressure gradient generated by a pump.Fluid removal with ultrafiltration presents several advantages such as elimination of higher amount of sodium with less neurohormonal activation.However,the conflicting results from UF studies highlight that patient selection and fluid removal targets are not completely understood.The best way to assess fluid status and therefore establish the fluid removal target is also still a matter of debate.Herein,we provide an up-to-date systematic review about the role of ultrafiltration among patients with fluid overload and its gaps in daily practice. | Andrea Urbani Filippo Pensotti Andrea Provera Andrea Galassi Marco Guazzi Diego Castini | 2023 | World Journal of Cardiology2023，15，5： | 0 |
| 9 | Untangling the difficult interplay between ischemic and hemorrhagic risk:The role of risk scores显示文摘BACKGROUND Bleedings are an independent risk factor for subsequent mortality in patients with acute coronary syndromes(ACS)and in those undergoing percutaneous coronary intervention.This represents a hazard equivalent to or greater than that for recurrent ACS.Dual antiplatelet therapy(DAPT)represents the cornerstone in the secondary prevention of thrombotic events,but the benefit of such therapy is counteracted by the increased hemorrhagic complications.Therefore,an early and individualized patient risk stratification can help to identify high-risk patients who could benefit the most from intensive medical therapies while minimizing unnecessary treatment complications in low-risk patients.AIM To review existing literature and gain better understanding of the role of ischemic and hemorrhagic risk scores in patients with ischemic heart disease(IHD).METHODS We used a combination of terms potentially used in literature describing the most common ischemic and hemorrhagic risk scores to search in PubMed as well as references of full-length articles.RESULTS In this review we briefly describe the most important ischemic and bleeding scores that can be adopted in patients with IHD,focusing on GRACE,CHA2DS2-Vasc,PARIS CTE,DAPT,CRUSADE,ACUITY,HAS-BLED,PARIS MB and PRECISE-DAPT score.In the second part of this review,we try to define a possible approach to the IHD patient,using the most suitable scores to stratify patient risk and decide the most appropriate patient treatment.CONCLUSION It becomes evident that risk scores by themselves can’t be the solution to balance the ischemic/bleeding risk of an IHD patient.Instead,some risk factors that are commonly associated with an elevated risk profile and that are already included in risk scores should be the focus of the clinician while he/she is taking care of a patient affected by IHD. | Simone Persampieri Diego Castini Alessandro Lupi Marco Guazzi | 2022 | World Journal of Cardiology2022，14，2： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员